Search hospitals > New York > New Hyde Park
The Steven and Alexandra Cohen Children's Medical Center of New York
Claim this profileNew Hyde Park, New York 11040
Global Leader in Cancer
Global Leader in Brain Tumor
Conducts research for Neuroblastoma
Conducts research for Solid Tumors
Conducts research for Acute Lymphoblastic Leukemia
137 reported clinical trials
8 medical researchers
Summary
The Steven and Alexandra Cohen Children's Medical Center of New York is a medical facility located in New Hyde Park, New York. This center is recognized for care of Cancer, Brain Tumor, Neuroblastoma, Solid Tumors, Acute Lymphoblastic Leukemia and other specialties. The Steven and Alexandra Cohen Children's Medical Center of New York is involved with conducting 137 clinical trials across 307 conditions. There are 8 research doctors associated with this hospital, such as Julie Krystal, Arlene Redner, MD, Mark P Atlas, MD, and Carolyn F. Levy.Area of expertise
1Cancer
Global LeaderStage IV
Stage I
Stage II
2Brain Tumor
Global LeaderStage I
Stage II
Stage IV
Top PIs
Julie KrystalThe Steven and Alexandra Cohen Children's Medical Center of New York8 years of reported clinical research
Expert in Neuroblastoma
Expert in Brain Tumor
24 reported clinical trials
41 drugs studied
Arlene Redner, MDThe Steven and Alexandra Cohen Children's Medical Center of New York6 years of reported clinical research
Studies Burkitt Lymphoma
Studies Biphenotypic Leukemia
11 reported clinical trials
39 drugs studied
Mark P Atlas, MDThe Steven and Alexandra Cohen Children's Medical Center of New York5 years of reported clinical research
Studies Brain Tumor
Studies Low Grade Glioma
10 reported clinical trials
24 drugs studied
Carolyn F. LevyThe Steven and Alexandra Cohen Children's Medical Center of New York8 years of reported clinical research
Studies Cancer
Studies Rhabdomyosarcoma
7 reported clinical trials
24 drugs studied
Clinical Trials running at The Steven and Alexandra Cohen Children's Medical Center of New York
Testicular cancer
Neuroblastoma
Acute Lymphoblastic Leukemia
Leukemia
Brain Tumor
Ovarian Carcinoma
Ovarian Tumors
Testicular Carcinoma
Ovarian Choriocarcinoma
Cancer
Chemotherapy
for Cancer
This phase III trial studies how well active surveillance help doctors to monitor subjects with low risk germ cell tumors for recurrence after their tumor is removed. When the germ cell tumor has spread outside of the organ in which it developed, it is considered metastatic. Chemotherapy drugs, such as bleomycin, carboplatin, etoposide, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. The trial studies whether carboplatin or cisplatin is the preferred chemotherapy to use in treating metastatic standard risk germ cell tumors.
Recruiting2 awards Phase 326 criteria
Chemotherapy + Radiation Therapy
for Brain Cancer
This phase II trial studies the best approach to combine chemotherapy and radiation therapy (RT) based on the patient's response to induction chemotherapy in patients with non-germinomatous germ cell tumors (NGGCT) that have not spread to other parts of the brain or body (localized). This study has 2 goals: 1) optimizing radiation for patients who respond well to induction chemotherapy to diminish spinal cord relapses, 2) utilizing higher dose chemotherapy followed by conventional RT in patients who did not respond to induction chemotherapy. Chemotherapy drugs, such as carboplatin, etoposide, ifosfamide, and thiotepa, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Radiation therapy uses high energy x-rays or high-energy protons to kill tumor cells and shrink tumors. Studies have shown that patients with newly-diagnosed localized NGGCT, whose disease responds well to chemotherapy before receiving radiation therapy, are more likely to be free of the disease for a longer time than are patients for whom the chemotherapy does not efficiently eliminate or reduce the size of the tumor. The purpose of this study is to see how well the tumors respond to induction chemotherapy to decide what treatment to give next. Some patients will be given RT to the spine and a portion of the brain. Others will be given high dose chemotherapy and a stem cell transplant before RT to the whole brain and spine. Giving treatment based on the response to induction chemotherapy may lower the side effects of radiation in some patients and adjust the therapy to a more efficient one for other patients with localized NGGCT.
Recruiting1 award Phase 2
Similar Hospitals nearby
Select from list below to view details
Frequently asked questions
What kind of research happens at The Steven and Alexandra Cohen Children's Medical Center of New York?
The Steven and Alexandra Cohen Children's Medical Center of New York is a medical facility located in New Hyde Park, New York. This center is recognized for care of Cancer, Brain Tumor, Neuroblastoma, Solid Tumors, Acute Lymphoblastic Leukemia and other specialties. The Steven and Alexandra Cohen Children's Medical Center of New York is involved with conducting 137 clinical trials across 307 conditions. There are 8 research doctors associated with this hospital, such as Julie Krystal, Arlene Redner, MD, Mark P Atlas, MD, and Carolyn F. Levy.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.